DNLI
Denali Therapeutics Inc
NASDAQ: DNLI · HEALTHCARE · BIOTECHNOLOGY
$18.60
-7.28% today
Updated 2026-04-29
Market cap
$2.95B
P/E ratio
—
P/S ratio
3,643.65x
EPS (TTM)
$-2.97
Dividend yield
—
52W range
$13 – $24
Volume
1.7M
Denali Therapeutics Inc (DNLI) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $129.16M | $26.68M | $335.66M | $48.66M | $108.46M | $330.53M | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | -79.3% | +1158.2% | -85.5% | +122.9% | +204.7% | -100.0% | — |
| Cost of revenue | $121000.00 | $1.47M | $74.46M | $143.18M | $193.38M | $212.62M | $5.61M | $7.03M | $16.73M | $7.79M | $11.18M |
| Gross profit | $-121000.00 | $-1.47M | $-74.46M | $129.16M | $26.68M | $335.66M | $48.66M | $108.46M | $330.53M | $-7.79M | $-11.18M |
| Gross margin | — | — | — | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | — | — |
| R&D | $11.57M | $75.70M | $74.46M | $143.18M | $193.38M | $212.62M | $265.35M | $358.73M | $423.88M | $396.44M | $418.78M |
| SG&A | $5.11M | $11.73M | $15.68M | $32.35M | $46.48M | $60.33M | $79.06M | $90.47M | $103.35M | $105.44M | $97.10M |
| Operating income | $-16.68M | $-87.43M | $-90.14M | $-46.37M | $-213.18M | $62.72M | $-295.75M | $-340.74M | $-196.70M | $-487.34M | $-555.34M |
| Operating margin | — | — | — | -35.9% | -799.1% | 18.7% | -607.8% | -314.2% | -59.5% | — | — |
| EBITDA | $-15.06M | $-85.96M | $-87.06M | $-38.96M | $-205.19M | $71.25M | $-287.16M | $-330.36M | $-179.97M | $-492.89M | $-497.63M |
| EBITDA margin | — | — | — | -30.2% | -769.1% | 21.2% | -590.1% | -304.6% | -54.4% | — | — |
| EBIT | $-15.18M | $-87.43M | $-90.14M | $-46.37M | $-213.18M | $62.72M | $-295.75M | $-340.74M | $-196.70M | $-501.88M | $-512.44M |
| Interest expense | $109000.00 | $0.00 | $1.96M | $1.96M | $15.22M | $17.77M | $13.19M | $14.77M | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-16.79M | $-86.65M | $-88.19M | $-36.24M | $-197.61M | $71.14M | $-290.58M | $-325.99M | $-145.22M | $-422.77M | $-512.54M |
| Net income growth (YoY) | — | -416.2% | -1.8% | +58.9% | -445.3% | +136.0% | -508.5% | -12.2% | +55.5% | -191.1% | -21.2% |
| Profit margin | — | — | — | -28.1% | -740.7% | 21.2% | -597.2% | -300.6% | -43.9% | — | — |